Chromadex Corp. (NASDAQ:CDXC)

About the company

Chromadex Corp. is a nutraceutical company. The firm engages in acquiring, developing and commercializing proprietary-based ingredient technologies. It operates through the following segments: Ingredients, Consumer Products, and Analytical Reference Standards and Services. The Ingredients segment offers NIAGEN in an ingredient form to partners. The Consumer Products segment sells TRU NIAGEN to improve health by safely raising NAD levels. The Analytical Reference Standards and Services segment provides product regulatory approval and scientific advisory services to the clients in the food, supplement, and pharmaceutical industries. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in September 1999 and is headquartered in Los Angeles, CA.

Sector

Process Industries

Industry

Chemicals: Specialty

Employees

110

CEO

Robert N. Fried

Exchange

NASDAQ

Website

http://www.chromadex.com

$51.00M

Total Revenue

110

Employees

$258.10M

Market Capitalization

-8.73

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$29M

Operating Margin (in %)

Total operating margin

$-29M

Net Margin (in %)

Total net margin

$-30M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Linde Plc LIN 116405.34 28023.00 2.52 49.72 8.35
Ecolab, Inc. ECL 58670.32 14982.00 6.45 37.85 10.32
Air Products & Chemicals, Inc. APD 54112.50 8978.00 4.73 27.86 21.66
Dow, Inc. DOW 30195.75 41752.00 2.34 -18.03 -4.01
LyondellBasell Industries NV LYB 22569.84 33443.00 2.99 8.40 8.11
Avantor, Inc. AVTR 9979.12 6079.00 6.94 -44.50 -3.72
Albemarle Corp. ALB 8336.37 3496.00 2.16 16.49 14.50
NewMarket Corp. NEU 4366.01 2213.00 6.79 15.99 12.52
Ashland Global Holdings, Inc. ASH 4247.62 2393.00 1.39 -45.67 -3.05
W.R. Grace & Co. GRA 3424.74 1910.00 9.10 24.13 7.52
Balchem Corp. BCPC 3027.75 661.00 3.87 37.00 12.20
Quaker Chemical Corp. KWR 2970.40 1301.00 2.84 -331.52 -0.81
Rogers Corp. ROG 2284.94 857.00 2.39 69.92 3.75
Stepan Co. SCL 2176.49 1820.00 2.45 20.89 5.81
PolyOne Corp. POL 2104.39 2823.00 1.56 3.52 20.65
Innospec, Inc. IOSP 1921.25 1497.00 2.00 16.32 7.79
PQ Group Holdings, Inc. PQG 1800.64 1569.00 1.04 23.23 4.88
Compass Minerals International, Inc. CMP 1667.70 1501.00 4.60 20.52 5.40
Minerals Technologies, Inc. MTX 1628.20 1770.00 1.15 12.27 7.47
Methanex Corp. MEOH 1384.72 3127.00 1.02 25.31 2.30
Kronos Worldwide, Inc. KRO 1140.28 1715.00 1.45 13.65 4.88
Renewable Energy Group, Inc. REGI 1065.54 2638.00 0.81 2.13 18.97
Tronox Holdings Plc TROX 993.25 2974.00 1.77 -23.62 -1.45
Livent Corp. LTHM 865.78 359.00 1.60 28.24 8.76
ChampionX Corp. CHX 761.28 1092.00 5.14 -1.26 -55.05
Codexis, Inc. CDXS 676.86 68.00 6.95 -46.68 -21.39
Westlake Chemical Partners LP WLKP 662.90 1043.00 2.39 10.46 6.11
Orion Engineered Carbons SA OEC 620.37 1428.00 3.68 7.26 6.02
Amyris, Inc. AMRS 548.13 167.00 -5.03 -1.84 -175.30
FutureFuel Corp. FF 500.28 210.00 1.40 4.88 48.49
Koppers Holdings, Inc. KOP 395.64 1797.00 3.99 7.45 2.98
REX American Resources Corp. REX 394.74 397.00 1.04 -137.06 -0.76
Green Plains, Inc. GPRE 379.99 2611.00 0.48 -2.71 -5.38
Loop Industries, Inc. LOOP 343.90 None 9.43 -23.82 None
Advansix, Inc. ASIX 333.76 1285.00 0.82 11.25 2.31
Valhi, Inc. VHI 293.77 1877.00 -7.98 5.28 2.95
Chromadex Corp. CDXC 258.10 51.00 16.48 -8.73 -58.73
Venator Materials Plc VNTR 191.53 2100.00 0.29 -1.16 -7.86
Rayonier Advanced Materials, Inc. RYAM 161.24 1744.00 0.27 -6.47 -1.71
Gulf Resources, Inc. GURE 53.50 11.00 0.20 -2.07 -219.83
Pacific Ethanol, Inc. PEIX 36.11 1380.00 0.21 -0.35 -7.42
Aemetis, Inc. AMTX 16.60 200.00 -0.10 -0.43 -19.06
Gevo, Inc. GEVO 6.24 22.00 0.11 -0.20 -145.04
CDTi Advanced Materials, Inc. CDTI 0.48 24.00 0.16 -0.08 -21.12

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Longmont lab earns accreditation for nutraceutical ingredient production

6d ago, source: The Business Journals

The company works with leading institutions like Harvard, the Mayo Clinic and Cambridge to have its ingredients studied and ...

Chromadex Corp (NASDAQ:CDXC) Shares Purchased by State Street Corp

3d ago, source: theenterpriseleader.com

State Street Corp lifted its holdings in Chromadex Corp (NASDAQ:CDXC) by 2.4% in the first quarter, according to its most ...

New Preclinical Findings Suggest Boosting NAD+ with Niagen® Holds Potential for Slowing Aging Process and Reducing Metabolic Damage

2d ago, source: YAHOO!

paving the way for further clinical research ChromaDex Corp. (NASDAQ:CDXC) today announced the results of multiple new preclinical studies that illustrate the multifaceted potential of Niagen ...

Chromadex Corp (NASDAQ:CDXC) Expected to Post Quarterly Sales of $13.56 Million

11d ago, source: theenterpriseleader.com

Brokerages forecast that Chromadex Corp (NASDAQ:CDXC) will announce $13.56 million in sales for the current quarter, Zacks ...

Chromadex (NASDAQ:CDXC) Raised to Buy at Zacks Investment Research

7d ago, source: modernreaders.com

Zacks Investment Research upgraded shares of Chromadex (NASDAQ:CDXC) from a hold rating to a buy rating in a research report ...

Zacks Investment Research Lowers Chromadex (NASDAQ:CDXC) to Hold

9d ago, source: modernreaders.com

Zacks Investment Research cut shares of Chromadex (NASDAQ:CDXC) from a buy rating to a hold rating in a report published on ...

ChromaDex’s QC, R&D facility receives ISO/IEC 17025:2017 accreditation

13d ago, source: Outlook

(Los Angeles, CA) earned ISO/IEC 17025:2017 accreditation for testing of the its Tru Niagen consumer products, Niagen ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.